InvestorsHub Logo

Prudent Capitalist

10/29/19 12:38 PM

#2829 RE: bar1080 #2827

WBA had a fine quarter. As pointed out by a number of commentators and analysts, the notion that Amazon was going to seriously wound WBA's prescription business did not come to pass. In fact, as detailed in WBA's Annual Report (10-K) just out, the pharmacy and prescription side of WBA's business increased relative to non-pharmacy, both in the US and Internationally. The market apparently recognizes this, and I expect WBA shares to trend higher coming out of this report.